醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
TEVA PHARMACEUTICAL INDUSTRIES LTD（TEVA）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $17.0M；高管董事有效買入 —、有效賣出 $14.4M。最近申報 2026-09-22。
買入 Bought—
賣出 Sold$17.0M
有效買入 Effective bought—
有效賣出 Effective sold$14.4M
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-18 | MIGNONE ROBERTO Director | 賣出 Sell · 有效 | 367,600 | $39.06 | $14.4M | SEC |
| 2026-09-18 | Savage Brian Interim Chief Legal Officer | 賣出 Sell | 7,342 | $38.85 | $285K | SEC |
| 2026-08-21 | Satchi-Fainaro Ronit Director | 賣出 Sell · 有效 | 415 | $37.25 | $15K | SEC |
| 2026-08-21 | Weiss Amir Chief Accounting Officer | 賣出 Sell | 9,445 | $37.62 | $355K | SEC |
| 2026-08-17 | Lippman Evan EVP, Business Development | 賣出 Sell | 18,600 | $36.57 | $680K | SEC |
| 2026-08-05 | Zaks Tal Zvi Director | 賣出 Sell · 有效 | 17 | $34.88 | $593 | SEC |
| 2026-08-03 | Hughes Eric A See "Remarks" | 賣出 Sell | 25,578 | $34.88 | $892K | SEC |
| 2026-08-03 | Jover Placid See "Remarks" | 賣出 Sell | 12,827 | $34.88 | $447K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-18 | Savage Brian Officer, CHIEF LEGAL OFFICER | 7,028 | $273K | |
| 2026-09-18 | BRIDGER MANAGEMENT, LLC Shareholder | 367,600 | $14.4M | |
| 2026-08-17 | Lippman Evan Officer, EVP BUSINESS DEVELOPMENT | 18,600 | $680K | 10b5-1 |
| 2026-08-03 | Hughes Eric A Executive VP Global R&D and Chief Med Officer | 25,578 | $892K | 10b5-1 |
| 2026-08-03 | Jover Placid Executive VP, Chief HR Officer | 12,827 | $447K | 10b5-1 |
內部人 Insiders
MIGNONE ROBERTO、Savage Brian、Satchi-Fainaro Ronit、Weiss Amir、Lippman Evan、Zaks Tal Zvi、Hughes Eric A、Jover Placid